The mechanism of the hyperglycaemic action of synthetic peptides related to the C-terminal sequence of human growth hormone.
D000273:Adipose Tissue / Q000187:drug effects / Q000201:enzymology*; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D006006:Glycogen Synthase / Q000378:metabolism*; D013006:Growth Hormone / Q000494:pharmacology*; D006943:Hyperglycemia / Q000139:chemically induced* / Q000378:metabolism; D007700:Kinetics; D007773:Lactates / Q000097:blood; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D010446:Peptide Fragments / Q000494:pharmacology*; D006005:Phosphorylases / Q000378:metabolism*; D011768:Pyruvate Dehydrogenase Complex / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains
D001786:Blood Glucose; D007773:Lactates; D010446:Peptide Fragments; D011768:Pyruvate Dehydrogenase Complex; C035326:somatotropin (176-191); C035327:somatotropin (177-191); D013006:Growth Hormone; D006005:Phosphorylases; D006006:Glycogen Synthase